Kidney Cancer Archives

Kidney Cancer

Benefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer

March 23, 2023

Updated analysis showed longer progression-free and overall survival for patients with advanced renal cell carcinoma.

Genitourinary Cancer

Partial Cytoreductive Nephrectomy Still Offers Survival Edge in Metastatic RCC

By

Jody A. Charnow

March 22, 2023

In a study, partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality.

In Patients With Renal Cell Carcinoma Receiving Everolimus, Acute Kidney Injury is Common

ONA Summit 2023

New Treatments, New Challenges in the Treatment of Bladder and Renal Cancers

By

Mary W. Dunn, MSN, RN, OCN, NP-C

March 18, 2023

A discussion of new treatment options that have improved prognosis for patients with bladder cancer and renal cell carcinoma is the focus of a presentation at the 2023 ONA Summit.

Kidney Cancer

Identifying and Managing Adverse Reactions to Lenvatinib and Pembrolizumab

By

Jen Smith

March 9, 2023

Researchers have characterized common adverse reactions to combination lenvatinib and pembrolizumab in patients with advanced renal cell carcinoma.

Oncology Nursing

Nurse-Parent Collaboration Key to Successful ¹³¹I-MIBG Therapy for Neuroblastoma

By

Jessica Nye, PhD

February 9, 2023

A qualitative descriptive study was conducted to learn about nurses’ experiences administering care to pediatric patients with neuroblastoma who are receiving radioactive therapy.

Kidney Cancer

Health-Related QOL Outcomes Superior With Higher Lenvatinib Starting Dose in RCC

By

Jessica Nye, PhD

February 6, 2023

Researchers randomly assigned patients with RCC to receive 18 mg or 14 mg of lenvatinib plus 5 mg everolimus to determine which produced better HRQOL.